Sweet Life: Insulin and Glucose Innovations 

Presenter: Nanjilis D. Padin Santos

Faculty Sponsor: Reena Randhir

School: Springfield Technical Community College

Research Area: Biology

Session: Poster Session 2, 11:30 AM - 12:15 PM, Auditorium, A11

ABSTRACT

This research explores the impact for diabetes management by the use of innovative technologies in clinal practice. These innovations focus on improving how insulin is delivered and how glucose can be monitored. By reviewing recent clinical studies and randomized trials in PubMed it was discovered that insulin pumps, modern insulin medications, like long-term and short-term acting insulin analogs plus continuous glucose monitoring systems significantly improves glycemic control in individuals with both type 1 and 2 diabetes. The way these technologies contribute is that they help with lowering HbA1c levels and reduce the frequency of hypoglycemic events. This is possible because of precise insulin dosage and real-time glucose data that supports timely clinical and patient decision-making. In addition, these studies demonstrate that this variation of tools that are used improves lowering the hemoglobin A1C levels by about 0.5-1.0% and a 37-38% reduction in hypoglycemia events accompanied with increased time-in-range and reduced glycemic variability. In addition, it brings more awareness to glucose monitoring for patients. It avoids the burden of frequent finger-stick testing and it minimizes the fluctuation of glucose in a patient, which improves their comfort and quality of life. The use of advanced insulin delivery technologies, including automated and hybrid closed-loop systems, provides greater flexibility and convenience, leading to improved patient satisfaction and treatment adherence. However, despite these benefits, these technologies are costly, and access remains limited for many patients. This can be due to many factors like insurance coverage, policies as well as socioeconomic and geographic disparities. Addressing these challenges can direct future research and updates on current policies. This will allow for broader access and can improve long-term and equitable outcomes for different populations of diabetic patients. 

RELATED ABSTRACTS